Skip to main content
Watch Insiders
KURAHealthcare

Kura Oncology Inc (KURA) Insider Trading

In the last 90 days, 7 Kura Oncology Inc (KURA) insiders reported 2 open-market purchases totaling $2,351,000 and 8 sales totaling $1,708,039. The most recent open-market purchase was reported on Aug 24, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$2,351,000
Corporate buyers
1
Latest transaction
Sep 29, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 29, 2026Kathleen FordChief Operating OfficerSale10,574$10.59$111,931
Sep 29, 2026Mollie LeoniChief Medical OfficerSale41,250$10.67$440,237
Sep 29, 2026Brian T. PowlChief Commercial OfficerSale32,450$10.63$345,034
Sep 28, 2026Teresa Brophy BairChief Legal OfficerSale8,442$10.50$88,618
Sep 28, 2026Thomas James DoyleSVP, Finance & AccountingSale4,607$10.50$48,361
Sep 24, 2026Francis BurrowsChief Scientific OfficerSale20,726$10.83$224,514
Aug 24, 2026Troy Edward WilsonPresident and CEOOpen Market Purchase100,000$12.39$1,239,000
Aug 21, 2026Brian T. PowlChief Commercial OfficerSale4,345$11.89$51,663
Aug 19, 2026Teresa Brophy BairChief Legal OfficerSale31,487$12.63$397,681
Aug 17, 2026Troy Edward WilsonPresident and CEOOpen Market Purchase100,000$11.12$1,112,000
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

KURA insider trading FAQ

Are KURA insiders buying or selling?
Over the last 90 days, KURA insiders were net buyers, reporting $2,351,000 of open-market purchases and $1,708,039 of sales.
When was the last KURA insider purchase?
The most recent open-market purchase of Kura Oncology Inc stock by an insider was reported on Aug 24, 2026, one of 2 purchases in the last 90 days.
Where does KURA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Kura Oncology Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.